YungShin Global Holding Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 5/6
YungShin Global Holding has been growing earnings at an average annual rate of 3.7%, while the Pharmaceuticals industry saw earnings growing at 8.8% annually. Revenues have been declining at an average rate of 3.4% per year. YungShin Global Holding's return on equity is 12.5%, and it has net margins of 14.2%.
Anahtar bilgiler
3.7%
Kazanç büyüme oranı
3.7%
EPS büyüme oranı
Pharmaceuticals Sektör Büyümesi | 18.5% |
Gelir büyüme oranı | -3.4% |
Özkaynak getirisi | 12.5% |
Net Marj | 14.2% |
Sonraki Kazanç Güncellemesi | 05 Nov 2024 |
Yakın geçmiş performans güncellemeleri
Recent updates
YungShin Global Holding (TWSE:3705) Is Due To Pay A Dividend Of NT$2.30
Jun 20YungShin Global Holding (TWSE:3705) Is Paying Out A Dividend Of NT$2.30
May 09YungShin Global Holding (TWSE:3705) Will Pay A Dividend Of NT$2.30
Apr 25YungShin Global Holding (TWSE:3705) Is Paying Out A Dividend Of NT$2.30
Apr 01With EPS Growth And More, YungShin Global Holding (TPE:3705) Is Interesting
Apr 05If You Had Bought YungShin Global Holding (TPE:3705) Stock A Year Ago, You Could Pocket A 10% Gain Today
Mar 16These 4 Measures Indicate That YungShin Global Holding (TPE:3705) Is Using Debt Reasonably Well
Feb 22Does YungShin Global Holding Corporation (TPE:3705) Have A Place In Your Dividend Portfolio?
Feb 05YungShin Global Holding Corporation's (TPE:3705) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Jan 18Here's Why I Think YungShin Global Holding (TPE:3705) Is An Interesting Stock
Dec 31If You Had Bought YungShin Global Holding (TPE:3705) Shares Three Years Ago You'd Have Earned 12% Returns
Dec 16YungShin Global Holding's (TPE:3705) Earnings Are Growing But Is There More To The Story?
Dec 01Gelir ve Gider Dağılımı
YungShin Global Holding nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
---|---|---|---|---|
30 Jun 24 | 7,437 | 1,053 | 1,770 | 331 |
31 Mar 24 | 7,154 | 922 | 1,744 | 314 |
31 Dec 23 | 7,028 | 827 | 1,718 | 330 |
30 Sep 23 | 6,861 | 703 | 1,680 | 347 |
30 Jun 23 | 6,765 | 716 | 1,650 | 328 |
31 Mar 23 | 7,029 | 787 | 1,841 | 350 |
31 Dec 22 | 7,312 | 839 | 2,037 | 347 |
30 Sep 22 | 7,617 | 963 | 2,247 | 353 |
30 Jun 22 | 8,017 | 882 | 2,437 | 386 |
31 Mar 22 | 7,981 | 796 | 2,409 | 392 |
31 Dec 21 | 7,805 | 737 | 2,370 | 395 |
30 Sep 21 | 7,938 | 721 | 2,351 | 424 |
30 Jun 21 | 7,857 | 721 | 2,325 | 423 |
31 Mar 21 | 7,879 | 703 | 2,329 | 415 |
31 Dec 20 | 8,085 | 792 | 2,310 | 411 |
30 Sep 20 | 8,146 | 839 | 2,344 | 401 |
30 Jun 20 | 8,259 | 800 | 2,440 | 411 |
31 Mar 20 | 8,383 | 836 | 2,485 | 408 |
31 Dec 19 | 8,192 | 749 | 2,518 | 398 |
30 Sep 19 | 8,012 | 678 | 2,478 | 416 |
30 Jun 19 | 7,826 | 727 | 2,377 | 401 |
31 Mar 19 | 7,559 | 700 | 2,298 | 380 |
31 Dec 18 | 7,514 | 702 | 2,262 | 371 |
30 Sep 18 | 7,223 | 642 | 2,203 | 334 |
30 Jun 18 | 7,061 | 561 | 2,079 | 309 |
31 Mar 18 | 6,823 | 516 | 1,942 | 344 |
31 Dec 17 | 6,623 | 514 | 1,832 | 352 |
30 Sep 17 | 6,418 | 507 | 1,736 | 321 |
30 Jun 17 | 6,271 | 505 | 1,715 | 327 |
31 Mar 17 | 6,298 | 683 | 1,728 | 312 |
31 Dec 16 | 6,191 | 658 | 1,731 | 322 |
30 Sep 16 | 6,174 | 862 | 1,688 | 329 |
30 Jun 16 | 6,076 | 983 | 1,659 | 331 |
31 Mar 16 | 6,031 | 838 | 1,618 | 301 |
31 Dec 15 | 6,034 | 893 | 1,564 | 301 |
30 Sep 15 | 5,981 | 745 | 1,506 | 376 |
30 Jun 15 | 5,968 | 719 | 1,485 | 370 |
31 Mar 15 | 5,926 | 736 | 1,478 | 393 |
31 Dec 14 | 5,827 | 720 | 1,468 | 379 |
30 Sep 14 | 5,706 | 763 | 1,467 | 305 |
30 Jun 14 | 5,555 | 707 | 1,430 | 319 |
31 Mar 14 | 5,267 | 658 | 1,381 | 341 |
31 Dec 13 | 5,062 | 619 | 1,344 | 348 |
Kaliteli Kazançlar: 3705 has high quality earnings.
Büyüyen Kar Marjı: 3705's current net profit margins (14.2%) are higher than last year (10.6%).
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: 3705's earnings have grown by 3.7% per year over the past 5 years.
Büyüme Hızlandırma: 3705's earnings growth over the past year (46.9%) exceeds its 5-year average (3.7% per year).
Kazançlar vs. Sektör: 3705 earnings growth over the past year (46.9%) exceeded the Pharmaceuticals industry -0.6%.
Özkaynak Getirisi
Yüksek ROE: 3705's Return on Equity (12.5%) is considered low.